Amgen Misses Estimates, Shares DropBiotechnology firm Amgen Inc. reported fourth-quarter profits, which fell shy of analysts’ expectations on Thursday, sending its shares lower by 1.6 percent.SavePrintFrank Yu1/27/2012|Updated: 1/27/2012Share this articleLeave a commentFrank YuAuthorAuthor’s Selected ArticlesTelegram’s $1.7 Billion Token Sale Dwarfs Year’s Biggest Tech IPOApr 13, 2018The Marketing Corner: Social Media PracticesJan 29, 2017Tackling the NFL on Taxes Dec 30, 2013Best and Worst Investments of 2013Dec 25, 2013Related Topicsbiotechnology
